Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.

[1]  D. M. Junqueira,et al.  HIV-1 subtype B: Traces of a pandemic. , 2016, Virology.

[2]  M. Talias,et al.  Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples , 2016, Expert review of pharmacoeconomics & outcomes research.

[3]  A. Urbańska,et al.  Distribution and time trends of HIV-1 variants in Poland: Characteristics of non-B clades and recombinant viruses. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[4]  M. Zazzi,et al.  HIV-1 A1 Subtype Epidemic in Italy Originated from Africa and Eastern Europe and Shows a High Frequency of Transmission Chains Involving Intravenous Drug Users , 2016, PloS one.

[5]  Sheena McCormack,et al.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial , 2016, The Lancet.

[6]  David Thompson,et al.  On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. , 2015, The New England journal of medicine.

[7]  G. Magiorkinis,et al.  Enhanced HIV-1 surveillance using molecular epidemiology to study and monitor HIV-1 outbreaks among intravenous drug users (IDUs) in Athens and Bucharest. , 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[8]  Don C Des Jarlais,et al.  Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. , 2015, Addiction.

[9]  M. Thomson,et al.  Bayesian phylogeographic analyses clarify the origin of the HIV-1 subtype A variant circulating in former Soviet Union's countries. , 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[10]  S. Bonovas,et al.  Big Events in Greece and HIV Infection Among People Who Inject Drugs , 2015, Substance use & misuse.

[11]  M. Poljak,et al.  Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast Asia. , 2015, The Journal of infectious diseases.

[12]  W. Guo,et al.  Development of an HIV-1 Subtype Panel in China: Isolation and Characterization of 30 HIV-1 Primary Strains Circulating in China , 2015, PloS one.

[13]  M. Abdi,et al.  Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran , 2015, PloS one.

[14]  S. Grigoryan,et al.  HIV Type 1 Subtype A1 Dominates in Armenia. , 2015, Current HIV research.

[15]  W. Hsu,et al.  CRF07_BC Strain Dominates the HIV-1 Epidemic in Injection Drug Users in Liangshan Prefecture of Sichuan, China. , 2015, AIDS research and human retroviruses.

[16]  Dan Otelea,et al.  Recent HIV-1 Outbreak Among Intravenous Drug Users in Romania: Evidence for Cocirculation of CRF14_BG and Subtype F1 Strains. , 2015, AIDS research and human retroviruses.

[17]  Jonathan E. Suk,et al.  National Income Inequality and Declining GDP Growth Rates Are Associated with Increases in HIV Diagnoses among People Who Inject Drugs in Europe: A Panel Data Analysis , 2015, PloS one.

[18]  C. Boesch,et al.  Origin of the HIV-1 group O epidemic in western lowland gorillas , 2015, Proceedings of the National Academy of Sciences.

[19]  M. Battegay,et al.  Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study , 2015, HIV medicine.

[20]  N. Ford,et al.  Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study. , 2015, The Lancet. Global health.

[21]  J. Pedrosa,et al.  Analysis of a Local HIV-1 Epidemic in Portugal Highlights Established Transmission of Non-B and Non-G Subtypes , 2015, Journal of Clinical Microbiology.

[22]  F. Altice,et al.  Challenges in managing HIV in people who use drugs , 2015, Current opinion in infectious diseases.

[23]  R. Paranjape,et al.  Undiagnosed HIV among people who inject drugs in Manipur, India , 2015, AIDS care.

[24]  D. Kuritzkes,et al.  Patients Infected with CRF07_BC Have Significantly Lower Viral Loads than Patients with HIV-1 Subtype B: Mechanism and Impact on Disease Progression , 2014, PloS one.

[25]  M. Suchard,et al.  The early spread and epidemic ignition of HIV-1 in human populations , 2014, Science.

[26]  S. S. Alinaghi,et al.  Subtype Classification of Iranian HIV-1 Sequences Registered in the HIV Databases, 2006-2013 , 2014, PloS one.

[27]  R. Paranjape,et al.  An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India. , 2014, The International journal on drug policy.

[28]  Yong-tang Zheng,et al.  Diverse forms of HIV-1 among Burmese long-distance truck drivers imply their contribution to HIV-1 cross-border transmission , 2014, BMC Infectious Diseases.

[29]  G. Gottlieb,et al.  Antiretroviral therapy response among HIV-2 infected patients: a systematic review , 2014, BMC Infectious Diseases.

[30]  LapovokIlya,et al.  Short Communication: Molecular Epidemiology of HIV Type 1 Infection in Kazakhstan: CRF02_AG Prevalence Is Increasing in the Southeastern Provinces , 2014 .

[31]  E. Kazennova,et al.  HIV-1 genetic variants in the Russian Far East. , 2014, AIDS research and human retroviruses.

[32]  W. Sugiura,et al.  Phylodynamic Analysis Reveals CRF01_AE Dissemination between Japan and Neighboring Asian Countries and the Role of Intravenous Drug Use in Transmission , 2014, PloS one.

[33]  Arielle Lasry,et al.  Estimating per-act HIV transmission risk: a systematic review , 2014, AIDS.

[34]  N. Gashnikova,et al.  HIV-1 genetic diversity in Russia: CRF63_02A1, a new HIV type 1 genetic variant spreading in Siberia. , 2014, AIDS research and human retroviruses.

[35]  M. Hellard,et al.  Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. , 2014, International journal of epidemiology.

[36]  Kok-Gan Chan,et al.  A Newly Emerging HIV-1 Recombinant Lineage (CRF58_01B) Disseminating among People Who Inject Drugs in Malaysia , 2014, PloS one.

[37]  James J. Goedert,et al.  Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada , 2013, PloS one.

[38]  A. Hatzakis,et al.  Economic Recession and Emergence of an HIV-1 Outbreak among Drug Injectors in Athens Metropolitan Area: A Longitudinal Study , 2013, PloS one.

[39]  Mustafizur Rahman,et al.  Molecular Dating of HIV-1 Subtype C from Bangladesh , 2013, PloS one.

[40]  M. Bobkova.  Current status of HIV-1 diversity and drug resistance monitoring in the former USSR. , 2013, AIDS reviews.

[41]  A. Haghdoost,et al.  HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey , 2013, Sexually Transmitted Infections.

[42]  M. Peeters,et al.  The origin and molecular epidemiology of HIV , 2013, Expert review of anti-infective therapy.

[43]  A. Abdul-Quader,et al.  Effectiveness of Structural-Level Needle/Syringe Programs to Reduce HCV and HIV Infection Among People Who Inject Drugs: A Systematic Review , 2013, AIDS and Behavior.

[44]  Gerra Gilberto,et al.  Dr. Gilberto Gerra, Chief of Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime (UNODC), Vienna. , 2013 .

[45]  D. Barouch,et al.  A global approach to HIV-1 vaccine development , 2013, Immunological reviews.

[46]  J. Wong,et al.  Current Trends of HIV Recombination Worldwide , 2013, Infectious disease reports.

[47]  M. Zhang,et al.  High Prevalence of HIV-1 Intersubtype B′/C Recombinants among Injecting Drug Users in Dehong, China , 2013, PloS one.

[48]  Y. Takebe,et al.  Molecular Diversity of HIV-1 among People Who Inject Drugs in Kuala Lumpur, Malaysia: Massive Expansion of Circulating Recombinant Form (CRF) 33_01B and Emergence of Multiple Unique Recombinant Clusters , 2013, PloS one.

[49]  H. Keyvani,et al.  Prevalence of Transmitted HIV Drug Resistance in Iran between 2010 and 2011 , 2013, PloS one.

[50]  Jerome H. Kim,et al.  Molecular Evolution of the HIV-1 Thai Epidemic between the Time of RV144 Immunogen Selection to the Execution of the Vaccine Efficacy Trial , 2013, Journal of Virology.

[51]  V. Lukashov,et al.  Distinct HIV type 1 strains in different risk groups and the absence of new infections by drug-resistant strains in Lithuania. , 2013, AIDS research and human retroviruses.

[52]  C. Bucello,et al.  Mortality among people who inject drugs: a systematic review and meta-analysis. , 2013, Bulletin of the World Health Organization.

[53]  A. Abdul-Quader,et al.  High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review , 2013, BMC Public Health.

[54]  Klaus Korn,et al.  HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics , 2013, Retrovirology.

[55]  C. Archibald,et al.  Geographical and temporal variation of injection drug users in Pakistan , 2013, Sexually Transmitted Infections.

[56]  H. Keyvani,et al.  Molecular epidemiology of HIV type 1 infection in Iran: genomic evidence of CRF35_AD predominance and CRF01_AE infection among individuals associated with injection drug use. , 2013, AIDS research and human retroviruses.

[57]  Qinggang Xu,et al.  Phylodynamics of HIV-1 unique recombinant forms in China-Myanmar border: implication for HIV-1 transmission to Myanmar from Dehong, China. , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[58]  Tomasz J. Wąsik,et al.  Molecular epidemiology of recent HIV‐1 infections in southern Poland , 2012, Journal of medical virology.

[59]  Xiang He,et al.  A Comprehensive Mapping of HIV-1 Genotypes in Various Risk Groups and Regions across China Based on a Nationwide Molecular Epidemiologic Survey , 2012, PloS one.

[60]  Y. Takebe,et al.  Genome Sequence of a Novel HIV-1 Circulating Recombinant Form 54_01B from Malaysia , 2012, Journal of Virology.

[61]  N. Gashnikova,et al.  Genetic characterization of an isolate of HIV type 1 AG recombinant form circulating in Siberia, Russia , 2012, Archives of Virology.

[62]  T. Leitner,et al.  Phylogenetic analysis of the Latvian HIV-1 epidemic. , 2012, AIDS research and human retroviruses.

[63]  Ujjwal Neogi,et al.  Molecular Epidemiology of HIV-1 Subtypes in India: Origin and Evolutionary History of the Predominant Subtype C , 2012, PloS one.

[64]  Yong-tang Zheng,et al.  Extensive and complex HIV-1 recombination between B’, C and CRF01_AE among IDUs in south-east Asia , 2012, AIDS.

[65]  S. Vermund,et al.  The HIV Epidemic: High-Income Countries. , 2012, Cold Spring Harbor perspectives in medicine.

[66]  S. Chuang,et al.  Molecular Epidemiology of HIV-1 Infection in Taiwan from 2005 to 2008: Further Spread of CRF07_BC and Emergence of CRF07_BC/Subtype B Dual Infection , 2012, Journal of acquired immune deficiency syndromes.

[67]  O. Kirk,et al.  The effect of injecting drug use history on disease progression and death among HIV‐positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis , 2012, HIV medicine.

[68]  S. Lata,et al.  Genetic architecture of HIV-1 genes circulating in north India & their functional implications , 2011, The Indian journal of medical research.

[69]  E. Gasich,et al.  A new unique recombinant HIV type 1 isolated from a child born to an HIV-infected mother. , 2011, AIDS research and human retroviruses.

[70]  S. Vermund,et al.  Antiretroviral drug resistance mutations among treated and treatment-naive patients in Pakistan: diversity of the HIV type 1 pol gene in Pakistan. , 2011, AIDS research and human retroviruses.

[71]  J. Minárovits,et al.  Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV type 1-infected, untreated patients in Hungary. , 2011, AIDS research and human retroviruses.

[72]  Phalguni Gupta,et al.  Origin and Dynamics of HIV-1 Subtype C Infection in India , 2011, PloS one.

[73]  N. Taveira,et al.  Origin and Epidemiological History of HIV-1 CRF14_BG , 2011, PloS one.

[74]  A. Hatzakis,et al.  HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[75]  P. Sharp,et al.  Origins of HIV and the AIDS pandemic. , 2011, Cold Spring Harbor perspectives in medicine.

[76]  N. Ford,et al.  Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda , 2011, Annals of Internal Medicine.

[77]  Michael Rayment.  Prevention of HIV-1 infection with early antiretroviral therapy , 2011, Journal of Family Planning and Reproductive Health Care.

[78]  S. Dixit,et al.  HIV-1 Circulating Recombinant Form in Nepal , 2011, Journal of Virology.

[79]  B. Haynes,et al.  Acute HIV-1 Infection. , 2011, The New England journal of medicine.

[80]  R. Gandhi,et al.  Update on human immunodeficiency virus (HIV)-2 infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  P. Ghys,et al.  Global trends in molecular epidemiology of HIV-1 during 2000–2007 , 2011, AIDS.

[82]  R. Avi,et al.  Emerging transmitted drug resistance in treatment-naïve human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia , 2011, Scandinavian journal of infectious diseases.

[83]  D. D. Des Jarlais,et al.  HIV Among Drug Users at Beth Israel Medical Center, New York City, the First 25 Years , 2011, Substance use & misuse.

[84]  David V Glidden,et al.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.

[85]  C. Brennan,et al.  Confirmation of Putative HIV-1 Group P in Cameroon , 2010, Journal of Virology.

[86]  C. Larsen,et al.  Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: A nationwide population-based cohort study , 2010, Scandinavian journal of infectious diseases.

[87]  T. Leitner,et al.  Dynamics of Two Separate but Linked HIV-1 CRF01_AE Outbreaks among Injection Drug Users in Stockholm, Sweden, and Helsinki, Finland , 2010, Journal of Virology.

[88]  D. Staneková,et al.  Genetic subtypes of HIV type 1 circulating in Slovakia. , 2010, AIDS research and human retroviruses.

[89]  D. Shepard,et al.  Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward , 2010, The Lancet.

[90]  O. Pybus,et al.  Explosive HIV-1 subtype B' epidemics in Asia driven by geographic and risk group founder events. , 2010, Virology.

[91]  W. Sugiura,et al.  HIV-2 CRF01_AB: First Circulating Recombinant Form of HIV-2 , 2010, Journal of acquired immune deficiency syndromes.

[92]  O. Pybus,et al.  Reconstructing the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC in East Asia: the relevance of genetic diversity and phylodynamics for vaccine strategies. , 2010, Vaccine.

[93]  E. Sanders-Buell,et al.  Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan. , 2010, AIDS research and human retroviruses.

[94]  S. Strathdee,et al.  Epidemiology of HIV Among Injecting and Non-injecting Drug Users: Current Trends and Implications for Interventions , 2010, Current HIV/AIDS reports.

[95]  O. Pybus,et al.  Identification of a Novel Second-Generation Circulating Recombinant Form (CRF48_01B) in Malaysia: A Descendant of the Previously Identified CRF33_01B , 2010, Journal of acquired immune deficiency syndromes.

[96]  S. Chuang,et al.  Molecular Epidemiology of HIV-1 Subtype B, CRF01_AE, and CRF07_BC Infection Among Injection Drug Users in Taiwan , 2010, Journal of acquired immune deficiency syndromes.

[97]  C. McArthur,et al.  Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low. , 2010, AIDS research and human retroviruses.

[98]  S. Chakrabarti,et al.  Molecular characterization of tat gene and long terminal repeat region of human immunodeficiency virus type-1 detected among the injecting drug users (IDUs) of Manipur, India: identification of BC recombinants. , 2010, Virus research.

[99]  Seyed Mohsen Mousavi,et al.  Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study , 2010, Archives of Virology.

[100]  Oliver Laeyendecker,et al.  HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda , 2009, AIDS.

[101]  S. Rowland-Jones,et al.  Two Distinct Epidemics: The Rise of HIV-1 and Decline of HIV-2 Infection Between 1990 and 2007 in Rural Guinea-Bissau , 2009, Journal of acquired immune deficiency syndromes.

[102]  V. Lukashov,et al.  Epidemiological networks and drug resistance of HIV type 1 in Krasnoyarsk region, Russia. , 2009, AIDS research and human retroviruses.

[103]  J. Carr,et al.  Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan. , 2009, AIDS research and human retroviruses.

[104]  Oliver G Pybus,et al.  Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam. , 2009, Virology.

[105]  J. H. Chen,et al.  Molecular Epidemiological Study of HIV-1 CRF01_AE Transmission in Hong Kong , 2009, Journal of acquired immune deficiency syndromes.

[106]  François Simon,et al.  A new human immunodeficiency virus derived from gorillas , 2009, Nature Medicine.

[107]  N. Taveira,et al.  Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[108]  Shigehiro Sato,et al.  Current HIV type 1 molecular epidemiology profile and identification of unique recombinant forms in Jakarta, Indonesia. , 2009, AIDS research and human retroviruses.

[109]  S. Chakrabarti,et al.  Implementation of a Multiregion Hybridization Assay to Characterize HIV-1 Strains Detected among Injecting Drug Users in Manipur, India , 2009, Intervirology.

[110]  S. Friedman,et al.  Theorizing "Big Events" as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks. , 2009, The International journal on drug policy.

[111]  S. Abbas,et al.  High prevalence of HIV infection among injection drug users (IDUs) in Hyderabad and Sukkur, Pakistan. , 2009, JPMA. The Journal of the Pakistan Medical Association.

[112]  M. Brůčková,et al.  A study of HIV-1 genetic diversity in the Czech Republic: 1986-2007. , 2008, Central European journal of public health.

[113]  R. Mattick,et al.  Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review , 2008, The Lancet.

[114]  Steven Wolinsky,et al.  Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960 , 2008, Nature.

[115]  A. Hatzakis,et al.  HIV epidemiology in Greece. , 2008, Future microbiology.

[116]  S. Rayner,et al.  The epidemic origin and molecular properties of B′: a founder strain of the HIV-1 transmission in Asia , 2008, AIDS.

[117]  B. Yip,et al.  Highly active antiretroviral therapy and survival in HIV-infected injection drug users. , 2008, JAMA.

[118]  O. Pybus,et al.  Temporal and Spatial Dynamics of Human Immunodeficiency Virus Type 1 Circulating Recombinant Forms 08_BC and 07_BC in Asia , 2008, Journal of Virology.

[119]  Mustafizur Rahman,et al.  Molecular evidence for polyphyletic origin of human immunodeficiency virus type 1 subtype C in Bangladesh. , 2008, Virus research.

[120]  Ross J. Harris,et al.  Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies , 2008, The Lancet.

[121]  Á. Holguín,et al.  Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain. , 2008, Current HIV research.

[122]  Oliver Laeyendecker,et al.  Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. , 2008, The Journal of infectious diseases.

[123]  S. Osmanov,et al.  New insights into the origin of the HIV type 1 subtype A epidemic in former Soviet Union's countries derived from sequence analyses of preepidemically transmitted viruses. , 2007, AIDS research and human retroviruses.

[124]  F. Buonaguro,et al.  HIV type 1 subtype A epidemic in injecting drug user (IDU) communities in Iran. , 2007, AIDS research and human retroviruses.

[125]  M. Thomson,et al.  Increasing HIV-1 genetic diversity in Europe. , 2007, The Journal of infectious diseases.

[126]  Gkikas Magiorkinis,et al.  Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin. , 2007, The Journal of infectious diseases.

[127]  N. Saksena,et al.  Emerging trends of HIV epidemiology in Asia. , 2007, AIDS reviews.

[128]  J. Carr,et al.  Genetic characterization of HIV-1 strains circulating in Kazakhstan. , 2007 .

[129]  M. Vaattovaara,et al.  HIV outbreak among injecting drug users in the Helsinki region: social and geographical pockets. , 2007, European journal of public health.

[130]  E. Sanders-Buell,et al.  Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand. , 2007, AIDS research and human retroviruses.

[131]  E. Sanders-Buell,et al.  A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35_AD. , 2007, AIDS research and human retroviruses.

[132]  M. Salemi,et al.  An outbreak of HIV-1 subtype G among Italian injecting drug users , 2007, AIDS.

[133]  Bhavna Chohan,et al.  HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. , 2007, The Journal of infectious diseases.

[134]  Y. Takebe,et al.  Identification of a Novel Circulating Recombinant Form (CRF33_01B) Disseminating Widely Among Various Risk Populations in Kuala Lumpur, Malaysia , 2006, Journal of acquired immune deficiency syndromes.

[135]  M. R. Khanani,et al.  HIV-1 subtype A infection in a community of intravenous drug users in Pakistan , 2006, BMC infectious diseases.

[136]  P. Sharp,et al.  Human immunodeficiency viruses: SIV infection in wild gorillas , 2006, Nature.

[137]  M. Salminen,et al.  HIV epidemiology in the Northwestern Federal District of Russia: dominance of HIV type 1 subtype A. , 2006, AIDS research and human retroviruses.

[138]  F. Buonaguro,et al.  Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran , 2006, Infectious Agents and Cancer.

[139]  S. V. Antonenko,et al.  Molecular epidemiology of HIV Type 1 in Ukraine: birthplace of an epidemic. , 2006, AIDS research and human retroviruses.

[140]  J. Carr,et al.  Genetic forms of HIV Type 1 in the former Soviet Union dominate the epidemic in Azerbaijan. , 2006, AIDS research and human retroviruses.

[141]  A. Mocroft,et al.  HIV-1 Subtypes and Response to Combination Antiretroviral Therapy in Europe , 2006, Antiviral therapy.

[142]  L. Wain,et al.  Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1 , 2006, Science.

[143]  S. Jameel,et al.  Molecular analysis and phylogenetic characterization of HIV in Iran , 2006, Journal of medical virology.

[144]  Linqi Zhang,et al.  An Epidemic of HIV Type I CRF07_BC Infection Among Injection Drug Users in Taiwan , 2006, Journal of acquired immune deficiency syndromes.

[145]  M. Gottlieb,et al.  Pneumocystis pneumonia--Los Angeles. , 2006, MMWR. Morbidity and mortality weekly report.

[146]  J. Carr,et al.  HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia. , 2006, AIDS research and human retroviruses.

[147]  B. Yip,et al.  Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort , 2006, AIDS.

[148]  T. Patterson,et al.  Complex Emergencies, HIV, and Substance Use: No “Big Easy” Solution , 2006, Substance use & misuse.

[149]  Kee Peng Ng,et al.  The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. , 2005, AIDS research and human retroviruses.

[150]  S. Chakrabarti,et al.  Determination of gag and env subtypes of HIV-1 detected among injecting drug users (IDUs) in Manipur, India: evidence for intersubtype recombination. , 2005, Virus research.

[151]  V. Lukashov,et al.  The HIV type 1 epidemic in Belarus: predominance of Eastern European subtype A strains and circulation of subtype B viruses. , 2005, AIDS research and human retroviruses.

[152]  Á. Holguín,et al.  HIV‐1 subtypes in Spain: a retrospective analysis from 1995 to 2003 , 2005, HIV medicine.

[153]  R. Villems,et al.  Predominance of a Rare Type of HIV-1 in Estonia , 2005, Journal of acquired immune deficiency syndromes.

[154]  N. Wolfe,et al.  Outbreak of a West African Recombinant of HIV-1 in Tashkent, Uzbekistan , 2005, Journal of acquired immune deficiency syndromes.

[155]  H. Schätzl,et al.  Genomic characterization of a novel HIV type 1 B/G intersubtype recombinant strain from an injecting drug user in Germany. , 2005, AIDS research and human retroviruses.

[156]  T. Rhodes,et al.  Transition and the HIV risk environment , 2005, BMJ : British Medical Journal.

[157]  Anne-Mieke Vandamme,et al.  Investigation of Baseline Susceptibility to Protease Inhibitors in HIV-1 Subtypes C, F, G and Crf02_Ag , 2005, Antiviral therapy.

[158]  V. Anttila,et al.  High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland , 2005, Scandinavian journal of infectious diseases.

[159]  S. Lai,et al.  Molecular Epidemiology of HIV-1 Subtypes in Southern China , 2005, Journal of acquired immune deficiency syndromes.

[160]  R. Paranjape,et al.  Subtype B and subtype C HIV type 1 recombinants in the northeastern state of Manipur, India. , 2005, AIDS research and human retroviruses.

[161]  A. Kamarulzaman,et al.  Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia , 2005, AIDS.

[162]  M. Salminen,et al.  Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia. , 2004, AIDS research and human retroviruses.

[163]  V. Pokrovsky,et al.  An HIV type 1 subtype A outbreak among injecting drug users in Kazakhstan. , 2004, AIDS research and human retroviruses.

[164]  J. Weber,et al.  Temporal trends in the HIV‐1 epidemic in Russia: Predominance of subtype A , 2004, Journal of medical virology.

[165]  W. Fawzi,et al.  Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D , 2004, AIDS.

[166]  T. Leitner,et al.  Rapid epidemic spread of HIV type 1 subtype A1 among intravenous drug users in Latvia and slower spread of subtype B among other risk groups. , 2004, AIDS research and human retroviruses.

[167]  M. Robb,et al.  The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002. , 2004, AIDS research and human retroviruses.

[168]  A. Telenti,et al.  HIV-1 co/super-infection in intravenous drug users , 2004, AIDS.

[169]  François Simon,et al.  Phylogenetic characteristics of three new HIV-1 N strains and implications for the origin of group N , 2004, AIDS.

[170]  Y. Takebe,et al.  Molecular epidemiology of HIV: Tracking AIDS pandemic , 2004, Pediatrics international : official journal of the Japan Pediatric Society.

[171]  Huynh Tan Tien,et al.  HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large predominance of CRF01_AE and presence of major resistance mutations to antiretroviral drugs. , 2003, AIDS research and human retroviruses.

[172]  Yutaka Takebe,et al.  High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination , 2003, AIDS.

[173]  N. Yuldasheva,et al.  Human immunodeficiency virus in Uzbekistan: epidemiological and genetic analyses. , 2003, AIDS research and human retroviruses.

[174]  J. Carr,et al.  A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand. , 2003, AIDS research and human retroviruses.

[175]  R. Parreira,et al.  Spreading of HIV-1 subtype G and envB/gagG recombinant strains among injecting drug users in Lisbon, Portugal. , 2003, AIDS research and human retroviruses.

[176]  M. Silvestre,et al.  Human immunodeficiency virus type 1 recombinant B/G subtypes circulating in Coimbra, Portugal. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[177]  M. Wainberg,et al.  A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors , 2003, AIDS.

[178]  S. Chakrabarti,et al.  HIV type 1 subtypes circulating in eastern and northeastern regions of India. , 2002, AIDS research and human retroviruses.

[179]  F. Brun-Vézinet,et al.  Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure. , 2002, Virology.

[180]  V. Lukashov,et al.  Simultaneous introduction of HIV type 1 subtype A and B viruses into injecting drug users in southern Ukraine at the beginning of the epidemic in the former Soviet Union. , 2002, AIDS research and human retroviruses.

[181]  J. Mcnicholl,et al.  Intersubtype Human Immunodeficiency Virus Type 1 Superinfection following Seroconversion to Primary Infection in Two Injection Drug Users , 2002, Journal of Virology.

[182]  M. Thomson,et al.  High Incidence of Non-B and Recombinant HIV-1 Strains in Newly Diagnosed Patients in Galicia, Spain: Study of Genotypic Resistance , 2002, Antiviral therapy.

[183]  K. Hertogs,et al.  CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. , 2002 .

[184]  M. Thomson,et al.  Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure. , 2002 .

[185]  R. Parreira,et al.  Molecular epidemiology of HIV type 1 infection in Portugal: high prevalence of non-B subtypes. , 2002, AIDS research and human retroviruses.

[186]  P. Sawanpanyalert,et al.  Co-existence of HIV-1 subtypes B' and E infections among Thai injecting drug users. , 2002, Asian Pacific journal of allergy and immunology.

[187]  G. Ahmed,et al.  Injecting drug users in Bangladesh: prevalence of syphilis, hepatitis, HIV and HIV subtypes. , 2002, AIDS.

[188]  J. Carr,et al.  Genetic subtypes of HIV type 1 viruses circulating in the Czech Republic. , 2001, AIDS research and human retroviruses.

[189]  D. Robertson,et al.  HIV type 1 genetic diversity and genotypic drug susceptibility in the Republic of Moldova. , 2001, AIDS research and human retroviruses.

[190]  J. Carr,et al.  First CRF01_AE/B recombinant of HIV-1 is found in Thailand. , 2001, AIDS.

[191]  M. Thomson,et al.  HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users , 2001, AIDS.

[192]  J. Weber,et al.  An HIV type 1 subtype A strain of low genetic diversity continues to spread among injecting drug users in Russia: study of the new local outbreaks in Moscow and Irkutsk. , 2001, AIDS research and human retroviruses.

[193]  H. Sato,et al.  Closely related HIV-1 CRF01_AE variant among injecting drug users in northern Vietnam: evidence of HIV spread across the Vietnam-China border. , 2001, AIDS research and human retroviruses.

[194]  Jie Chen,et al.  A Recent Outbreak of Human Immunodeficiency Virus Type 1 Infection in Southern China Was Initiated by Two Highly Homogeneous, Geographically Separated Strains, Circulating Recombinant Form AE and a Novel BC Recombinant , 2000, Journal of Virology.

[195]  Y. Takebe,et al.  Emergence of new forms of human immunodeficiency virus type 1 intersubtype recombinants in central Myanmar. , 2000, AIDS research and human retroviruses.

[196]  M. Salminen,et al.  An outbreak of the circulating recombinant form AECM240 HIV-1 in the Finnish injection drug user population. , 2000, AIDS.

[197]  C. Kuiken,et al.  Genetic analysis reveals epidemiologic patterns in the spread of human immunodeficiency virus. , 2000, American journal of epidemiology.

[198]  S. Osmanov,et al.  An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network. , 2000, AIDS research and human retroviruses.

[199]  A. Lapedes,et al.  Timing the ancestor of the HIV-1 pandemic strains. , 2000, Science.

[200]  T. Saraswathy,et al.  Human immunodeficiency virus type 1 subtypes among Malaysian intravenous drug users. , 2000, Southeast Asian Journal of Tropical Medicine and Public Health.

[201]  W. Heneine,et al.  Human immunodeficiency virus type 2 (HIV‐2) in Portugal: Clinical spectrum, circulating subtypes, virus isolation, and plasma viral load , 2000, Journal of medical virology.

[202]  A. De Rossi,et al.  Different distribution of HIV type 1 genetic variants in European patients with distinct risk practices. , 2000, AIDS research and human retroviruses.

[203]  N. Deacon,et al.  The Explosive Human Immunodeficiency Virus Type 1 Epidemic among Injecting Drug Users of Kathmandu, Nepal, Is Caused by a Subtype C Virus of Restricted Genetic Diversity , 2000, Journal of Virology.

[204]  Jie Chen,et al.  Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia , 2000, AIDS.

[205]  J. Goudsmit,et al.  Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections. , 1999, AIDS research and human retroviruses.

[206]  J. Albert,et al.  An HIV type 1 subtype A outbreak among injecting drug users in Latvia. , 1999, AIDS research and human retroviruses.

[207]  W. Liu,et al.  Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China. , 1999, Journal of acquired immune deficiency syndromes.

[208]  H. Sato,et al.  Genetic similarity of HIV type 1 subtype E in a recent outbreak among injecting drug users in northern Vietnam to strains in Guangxi Province of southern China. , 1999, AIDS research and human retroviruses.

[209]  V. Trouplin,et al.  Predominance of CCR5-dependent HIV-1 subtype E isolates in Cambodia. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[210]  F. Gao,et al.  Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes , 1999, Nature.

[211]  C. Beyrer,et al.  HIV type 1 subtypes in Malaysia, determined with serologic assays: 1992-1996. , 1998, AIDS research and human retroviruses.

[212]  H. Sato,et al.  Genetic and serologic characterization of HIV type 1 prevailing in Myanmar (Burma). , 1998, AIDS research and human retroviruses.

[213]  M. Salminen,et al.  HIV‐1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad , 1998, AIDS.

[214]  J. Goudsmit,et al.  Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus. , 1998, AIDS research and human retroviruses.

[215]  F. Brun-Vézinet,et al.  Identification of a new human immunodeficiency virus type 1 distinct from group M and group O , 1998, Nature Medicine.

[216]  P. Reuter.  World drug report , 1998 .

[217]  M. Essex,et al.  Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine. , 1998, AIDS research and human retroviruses.

[218]  C. Luo,et al.  HIV type 1 in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity. , 1998, AIDS research and human retroviruses.

[219]  M. Graf,et al.  Sequence Note: Cloning and Characterization of a Virtually Full-Length HIV Type 1 Genome from a Subtype B'-Thai Strain Representing the Most Prevalent B-Clade Isolate in China , 1998 .

[220]  B. Korber,et al.  An African HIV-1 sequence from 1959 and implications for the origin of the epidemic , 1998, Nature.

[221]  Martine Peeters,et al.  Geographical distribution of HIV‐1 group O viruses in Africa , 1997, AIDS.

[222]  C. Luo,et al.  Sequence Note: HIV Type 1 Subtypes in Malaysia Include B, C, and E , 1996 .

[223]  D. Vlahov,et al.  Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe. , 1996, AIDS research and human retroviruses.

[224]  H. Fleury,et al.  HIV type 1 Thai subtype E is predominant in South Vietnam. , 1996, AIDS research and human retroviruses.

[225]  J. Goudsmit,et al.  Simultaneous introduction of distinct HIV‐1 subtypes into different risk groups in Russia, Byelorussia and Lithuania , 1995, AIDS.

[226]  J. Mullins,et al.  Identification of an env G subtype and heterogeneity of HIV‐1 strains in the Russian Federation and Belarus , 1994, AIDS.

[227]  S. Chamaret,et al.  Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. , 1994, Virology.

[228]  J. Mandel,et al.  Injecting drug use and HIV infection in southwest China , 1994, AIDS.

[229]  S. Knapp,et al.  A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon , 1994, Journal of virology.

[230]  H. Gayle,et al.  Risk factors for HIV infection among abandoned Romanian children , 1993, AIDS.

[231]  H. Gayle,et al.  Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand , 1993, The Lancet.

[232]  F. Gao,et al.  Human infection by genetically diverse SIVSM-related HIV-2 in West Africa , 1992, Nature.

[233]  D. Heymann,et al.  Acquired immunodeficiency syndrome in Romania , 1991, The Lancet.

[234]  F. Brun-Vézinet,et al.  Isolation of a new human retrovirus from West African patients with AIDS. , 1986, Science.

[235]  R. Kodsi,et al.  EVIDENCE FOR HUMAN INFECTION WITH AN HTLV III/LAV-LIKE VIRUS IN CENTRAL AFRICA, 1959 , 1986, The Lancet.

[236]  B. Haynes,et al.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. , 1984, Science.

[237]  P. Francioli,et al.  Clinical and epidemiological survey of acquired immune deficiency syndrome in Europe , 1984, European Journal of Clinical Microbiology.

[238]  J. Chermann,et al.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.

[239]  M. Gottlieb,et al.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. , 1981, The New England journal of medicine.

[240]  La Vita.  The Genetic Variability of HIV-1 in Kyrgyzstan: The Spread of CRF02_AG and Subtype A1 Recombinants , 2015 .

[241]  A. Pharris,et al.  Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. , 2014, The International journal on drug policy.

[242]  D. Staneková,et al.  Distribution of HIV-1 subtypes circulating in Slovakia (2009-2012). , 2014, Acta virologica.

[243]  M. Poljak,et al.  HIV‑1 molecular epidemiology in the Balkans: a melting pot for high genetic diversity. , 2012, AIDS reviews.

[244]  Y. Takebe,et al.  Global molecular epidemiology of HIV: understanding the genesis of AIDS pandemic. , 2008, Advances in pharmacology.

[245]  M. T. Paixão,et al.  Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal. , 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[246]  H. Sato,et al.  HIV type 1 env subtype E in Cambodia. , 1999, AIDS research and human retroviruses.

[247]  F. Muggia,et al.  Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California. , 1981, MMWR. Morbidity and mortality weekly report.